duopoly model by considering the pseudo-generics production as a mergers' catalyst. We show that a brand-name company always … its merger gain by producing pseudo-generics beforehand. In some cases, pseudo-generics would not otherwise be produced … increasing their market share, some brand-name firms produce generics themselves, called pseudo- generics. We develop a Cournot …

duopoly model by considering the pseudo-generics production as a mergers’ catalyst. We show that a brand-name company always … its merger gain by producing pseudo-generics beforehand. In some cases, pseudo-generics would not otherwise be produced … increasing their market share, some brand-name firms produce generics themselves, called pseudo- generics. We develop a Cournot …

, either directly or through license agreements. Although claims that these pseudo-generics may have anti-competitive effects …

generics themselves, called pseudo-generics. We show, in a duo-poly model with substitutable goods, in which a brand-name firm … often, an incentive to produce pseudo-generics. …

generics themselves, called pseudo-generics, enabling them to set up barriers to entry. We develop this topic by considering … the pseudo-generics production as a mergers.catalyst. We show, in a duopoly model with substitutable goods, in which a … competitor. The key insight of this paper is that the brand-name laboratory can increase its merger gain by producing pseudo-generics …